September 11, 2024. T-CURX presents at the Advanced Therapies Europe conference in Estoril, Portugal

T-CURX CEO, Ulf Grawunder, PhD, and Head of Preclinical Research, Jan Van den Brulle, PhD, are attending the 2024 Advanced Therapies Week Europe in Portugal. T-CURX CEO, Ulf Grawunder will present a latest update on T-CURX technology and pipeline programs

The Advanced Therapies Europe (ATE) conference in September 2024 is Phacilitate's flagship conference in Europe focusing on innovations in the field of Cell and Gene Therapy. The 2024 ATE takes place in the Estoril Congress Center in Estoril, Portugal.

T-CURX' leadersip team members, Ulf Grawunder, CEO, and Jan Van den Brulle, Head iof Preclinical Research are attending this years conference and meeting with industry leaders.

Furthermore, Ulf Grawunder will present an update on the company's CAR-T development activities, including technology development and CAR-T pipeline products. His presentation will take place during the "Innovation Spotligt Session" on Wednesday, Sep 11, from 11:15 a.m. until 12:15 p.m.